Call(WhatsApp Us)
+8615360806100Email Us
cherry@laeyo.comSee the factory by live video walkthrough
Book an on-site factory visit in GuangzhouMost skincare brands approach the Gulf with one "Middle East" dossier, one English label file, and one assumption: that a product cleared in one country will slide into the next. In practice, Qatar and…
Most skincare brands approach the Gulf with one “Middle East” dossier, one English label file, and one assumption: that a product cleared in one country will slide into the next. In practice, Qatar and Kuwait each review the same jar of cream through a different lens — a different licensed importer carrying legal responsibility, a different import and product-conformity route, different label-language expectations, and a different documentary ask at the border. The formula often travels unchanged. The evidence pack, the artwork, and the accountable entity almost never do. This guide is written for brand owners and sourcing managers who need to plan both markets in parallel without rebuilding the product twice — and it focuses on what to verify, what to request from your manufacturer, and which items must never be cut to save time.
Treating the Gulf as a single regulatory block is the most common and most expensive shortcut in skincare sourcing. The moment a brand says “we want to sell into the Middle East,” the correct response is a set of narrowing questions, not a quotation.
A registration completed in Dubai does not automatically extend across the GCC, and a partner licensed in one Gulf state cannot act as your responsible entity in another. Any supplier offering a single “Middle East certificate” that covers Qatar, Kuwait, and Saudi Arabia at once is describing a document that does not exist.
The formula is rarely the problem. The divergence sits in the paperwork, the artwork, and the accountable party. Use the table below as a working agenda with your importer — and get each row answered in writing before you lock artwork.
| Dossier item | Why it does not travel between Qatar and Kuwait | What to request (evidence) |
|---|---|---|
| Local responsible entity / importer | Each market requires a locally licensed importer or notifier to hold the product and its claims. A partner licensed in one country cannot act in the other. | Signed agency / authorization letter naming the exact brand and product, plus a copy of the importer’s trade license. |
| Import and product-conformity documents | Port authorities and importers ask for different combinations of Free Sale, Conformity, origin, and legalization documents — and validity windows differ. | A written document list from the importer, including expiry windows for each certificate before the shipment lands. |
| Label language and mandatory content | Arabic-only versus Arabic plus English acceptance is a market and importer decision; mandatory fields such as importer name and address must match the actual entity. | Approved artwork in the accepted language version, plus a written label compliance review before print. |
| Ingredient restrictions and fragrance allergen disclosure | Restricted-ingredient lists and allergen disclosure thresholds are set per market, not per region — and they apply to the fragrance as dosed in your formula. | IFRA certificate and an allergen declaration calculated against the actual fragrance dosage, not a generic “fragrance-free of restricted substances” statement. |
| SDS and transport classification | Alcohol content, flash point, and pack size drive dangerous-goods classification and therefore the shipping paperwork. | SDS prepared for the exact shipping version and pack size, plus a DG declaration where applicable. |
| Claims review | A line that reads as cosmetic in one market can be read as therapeutic in another, which changes the product’s classification rather than just its copy. | A claim-by-claim table with the support evidence for each line, reviewed before translation and before print. |
| Stability and packaging compatibility | Transit and warehouse conditions in the Gulf differ from the EU/US baseline most stability protocols were designed around. | Elevated-temperature stability data plus a packaging compatibility report covering leakage, pump function, and label adhesion. |
These decisions are cheapest before the first pilot batch and most expensive after the artwork is printed.
Send this list as a single request. A manufacturer who can answer it in one pass is a manufacturer who has exported to the region before.
Because the submissions run in parallel but the evidence is shared, the critical path is almost always testing plus label approval — not production.
Symptom: Shipment held at the port despite a complete technical file.
Root cause: One artwork file was produced for “the Gulf,” so the named entity does not match the licensed importer in the destination country.
Prevention: Treat each country’s artwork as a separate SKU with its own approval record.
Evidence to request: Importer trade license plus a signed authorization letter, matched line by line against the printed artwork.
Symptom: Returns and marketplace complaints in the first weeks after launch; no defect found in the retained sample.
Root cause: The pack was validated at ambient laboratory conditions rather than under elevated temperature and humidity, and the closure was never tested against the actual fill viscosity.
Prevention: Require a packaging compatibility report on the retail pack, including transit simulation and label adhesion.
Evidence to request: Compatibility report naming the specific bottle, pump, and liner, with the fill viscosity recorded.
Symptom: Label review bounces back, or a reformulation forces a reprint.
Root cause: A generic fragrance statement was supplied instead of a declaration calculated at the use level.
Prevention: Freeze the fragrance dosage before artwork and recalculate if it changes.
Evidence to request: IFRA certificate plus an allergen declaration stating the dosage it was calculated against.
Symptom: The importer cannot complete the file, or the COA does not match the shipped batch.
Root cause: COA, SDS, and stability reports were issued for a development batch rather than the production batch.
Prevention: Make batch-specific documentation a release condition, not an afterthought.
Evidence to request: Batch record, batch-specific COA, and retained-sample confirmation for the exact lot shipped.
Symptom: The product is questioned at review, and the whole ordinary-cosmetic route stalls.
Root cause: Marketing copy borrowed from another market implied a therapeutic or structural effect.
Prevention: Run a claim-by-claim review before translation, with each line mapped to evidence.
Evidence to request: A signed claim substantiation table covering every on-pack and listing claim.
Symptom: A shipment that was compliant at booking is non-compliant on arrival.
Root cause: Certificates of Free Sale and Conformity have short validity windows and were issued too early in the project.
Prevention: Sequence certificate issuance against the shipment date, not the project kickoff.
Evidence to request: Issue and expiry dates for every certificate, checked against the planned sailing date.
No. Each market has its own import and product-conformity requirements, administered nationally and executed through a locally licensed importer or notifier. A registration completed in one Gulf state should be treated as covering that state only, and the requirements for the second market must be verified separately.
Not on the strength of that registration. A Dubai registration does not automatically extend across the GCC, and a single generic “Middle East certificate” cannot substitute for the country-specific documents your importer will be asked to produce.
Usually not. One core formula can serve both markets, but the label language, allergen disclosure, claims set, and document pack are built per country. If a restricted-ingredient or allergen threshold forces a formula change, it must happen before the artwork and the safety file are finalized — not after.
The local importer or notifier, not the factory and typically not the overseas brand. That entity handles the submission, the label compliance check, and post-market obligations. This is why the importer’s licensed details must appear on the artwork and why an authorization letter is a core document rather than a formality.
The critical path is testing plus label approval, not production. Plan the stability and compatibility window first, run the two importers’ reviews in parallel on the same test data, and time certificate issuance against the actual shipment date so nothing expires in transit.
This article is informational only and does not constitute legal or regulatory advice. Confirm the applicable requirements with your licensed importer and the relevant national authority before committing to artwork, claims, or shipment.
If you are planning a Qatar and Kuwait launch on a shared formula, the fastest way to a usable quotation is to send four things: your target markets, your SKU list and formats, your positioning and claim direction, and your packaging preference. Share those and our team will map the evidence pack each market needs. Request a Quote.